Nourish Raises $100M to Scale AI-Native Metabolic Health Platform
Nourish, a U.S.-based AI-driven metabolic health clinic, raised $100 million in Series C funding led by Menlo Ventures to expand its dietitian-led care model across all 50 states, targeting chronic diseases affecting nearly 200 million Americans. The company’s AI-supported approach delivers personalized care, achieving an average 8% weight loss and $2,000 in annual cost savings per patient for health plans, while integrating GLP-1 medication management and provider AI tools for efficiency.
Nourish, the leading dietitian-led metabolic health clinic in the U.S., has secured $100 million in Series C funding to accelerate expansion of its AI-native platform. The round was led by Menlo Ventures, with participation from Thrive Capital, Index Ventures, J.P. Morgan Growth Equity Partners, Maverick Ventures, and Y Combinator, bringing the company’s valuation to $1.75 billion. Nourish’s model combines nutritional, medical, and technological care to address chronic diseases linked to metabolic health, serving over 200 million insured Americans nationwide. The company targets a critical healthcare gap: nearly 200 million Americans live with metabolic-related conditions, driving significant U.S. healthcare spending and over one million preventable deaths annually. Nourish delivers care through registered dietitians supported by AI systems, offering personalized plans that include nutrition guidance, lab testing, and medical support. GLP-1 medications are integrated where clinically appropriate, but the company emphasizes ongoing support to prevent treatment discontinuation and weight regain. CEO Aidan Dewar highlighted the fragmented, reactive nature of the U.S. healthcare system, positioning Nourish as a solution with continuous, coordinated metabolic care. Clinical outcomes show patients achieve an average 8% weight loss, alongside improvements in A1C, LDL cholesterol, and blood pressure—resulting in over $2,000 in annual cost savings per patient for health plans. Investor confidence stems from Nourish’s rapid growth, with over 10,000 registered dietitians and millions of patient appointments completed. The company has partnerships with more than 250 health systems for patient referrals, ensuring broad access. Menlo Ventures partner J.P. Sanday joined the board, calling chronic disease a major healthcare failure and praising Nourish’s ability to improve outcomes and cost efficiency. Nourish plans to expand its AI infrastructure, including health agents for patient engagement via mobile apps and AI copilots for providers to streamline administrative tasks. The company’s focus on scalable, data-driven metabolic care aligns with growing demand for digital health solutions addressing chronic disease prevention and management.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.